Divi's Laboratories is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment between Rs 650 crore to Rs 700 crore, to be funded from internal accruals.

The proposed facility is expected to be operational around January, 2027.

"The company is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment of ₹650 crore to ₹700 crore," the company said in a stock exchange filng.

It added that the same would be funded via internal accruals. The proposed facility is estimated to be operational around January 2027.

Divi's Laboratories said it could not disclose any further details because of the confidentiality agreement it had signed with the customer.